REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/10/2025
Back to search
Official data from USPTO
HOMPPYGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
03/10/2025
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
08/07/2019
Registration date
03/10/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2020
Last transaction
03/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/18/2019
First use in commerce
07/18/2019
Drawing code
3
Owner type
99
Owner location
Colorado Springs, CO
Examiner
BERLIN, JUSTIN
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Homppygene Healthcare & Technology International Limited
Representatives
HAO NI NI, WANG & MASSAND, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-itch ointment; Babies' diaper-pants; Capsules sold empty for pharmaceuticals; Corn plasters; Dietary and nutritional supplements used for weight loss; Eyepatches for medical purposes; Ginseng capsules for medical purposes; Herbal teas for medicinal purposes; Medical plasters; Nursing pads; Nutraceuticals for use as a dietary supplement; Probiotic supplements; Protein supplements; Sexual stimulant gels; Vaginal preparationsantifungals; Wound dressings; Dietary supplement for eliminating toxins from the intestinal tract; Disinfectants; Medicated ointments for treating dermatological conditions; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pregnancy test kits for home use
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/24/2019
PUBO
PUBLISHED FOR OPPOSITION
12/24/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2019
ALIE
ASSIGNED TO LIE
11/18/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/13/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
11/13/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/13/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
11/13/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/13/2019
DOCK
ASSIGNED TO EXAMINER
11/06/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/24/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/23/2019
NWAP
NEW APPLICATION ENTERED
08/10/2019
Continuous trademark protection
Get notified about every new filing that threatens HOMPPYGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.